[cited 2026 Jan 20];56 10.1097/MCG.0000000000001561
However, like all medications, they may be associated with certain side effects, such as gastrointestinal issues, including nausea, vomiting, diarrhea, and constipation
Knowing your peptide-pathway genetic profile can enrich conversations with your provider about whether liraglutide aligns with your biology, whether dosing adjustments might optimize results, or whether an alternative GLP-1 agent (semaglutide, tirzepatide) better suits your genetic predispositions
Competition among GLP-1 drugs could have a moderating effect on launch prices and lead to higher rebates negotiated between manufacturers and pharmacy benefit managers
J Neurochem (2005) 92(4):798806
Regeneron Pharmaceuticals Sector: Muscle-preserving antibody combinations and GLP-1 therapy for obesity HQ: Tarrytown, NY Year Founded: 1988 Origin Story: Founded in 1988 by Leonard Schleifer, MD, PhD, a neurologist and assistant professor at Cornell University Medical College on the premise that drug discovery could be industrialized through proprietary antibody-generation technology